Dr. Karandikar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2015 - 2018
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 2012 - 2015
- Wayne State University School of MedicineClass of 2012
Certifications & Licensure
- CA State Medical License 2013 - 2025
- MA State Medical License 2015 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 51 citationsMulticenter study of the risk factors for colonization or infection with carbapenem-resistant Enterobacteriaceae in childrenKathleen Chiotos, Pranita D. Tamma, Kelly B. Flett, Matthew E. Naumann, Manjiree V. Karandikar
Antimicrobial Agents and Chemotherapy. 2017-11-22 - 31 citationsIncreased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.Kathleen Chiotos, Pranita D. Tamma, Kelly B. Flett, Manjiree V. Karandikar, Koorosh Nemati
Open Forum Infectious Diseases. 2018-09-10 - 8 citationsSafety and Tolerability of Moxifloxacin in Children.Avika Dixit, Manjiree V. Karandikar, Sarah Jones, Mari M. Nakamura
Journal of the Pediatric Infectious Diseases Society. 2018-08-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: